Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

Back to Item »

Sandoz' Rituximab Biosimilar Rixathon Wins EC Clearance

The European Commision (EC) approved Sandoz’ Rixathon ® biosimilar of Roche’s blockbuster monoclonal antibody (mAb) rituximab (MabThera ® /Rituxan ...

Forward this item to a colleague:


(Separate multiple addresses by commas)